Misao R, Fujimoto J, Nakanishi Y, Tamaya T
Department of Obstetrics and Gynecology, Gifu University School of Medicine, Japan.
J Steroid Biochem Mol Biol. 1997 Aug;62(5-6):385-90. doi: 10.1016/s0960-0760(97)00051-4.
We have demonstrated the expression of sex hormone-binding globulin (SHBG) exon VII splicing variant mRNA in human uterine endometrium, using the reverse transcription-polymerase chain reaction-Southern blot and DNA sequencing analyses. Analysis of the missing base pairs corresponded to the entire exon VII, which are considered to encode a portion of the steroid-binding site. Therefore, the steroid-binding affinity of this variant might be different from that of the SHBG wild type. In uterine endometria, the wild-type and variant mRNA levels tended to increase with the advance of the menstrual phase, but the ratio of the SHBG variant mRNA to SHBG wild-type mRNA levels showed no significant difference during the menstrual cycle. So far, there are no indications that the SHBG variant has any biological or clinical implications in human uterine endometrium.
我们通过逆转录-聚合酶链反应- Southern印迹法和DNA测序分析,证实了性激素结合球蛋白(SHBG)外显子VII剪接变体mRNA在人子宫内膜中的表达。对缺失碱基对的分析对应于整个外显子VII,其被认为编码类固醇结合位点的一部分。因此,该变体的类固醇结合亲和力可能与SHBG野生型不同。在子宫内膜中,野生型和变体mRNA水平倾向于随着月经周期的推进而增加,但在月经周期中,SHBG变体mRNA与SHBG野生型mRNA水平的比值没有显著差异。到目前为止,没有迹象表明SHBG变体在人子宫内膜中有任何生物学或临床意义。